Nature Communications (May 2017)

Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens

  • David W. Morgens,
  • Michael Wainberg,
  • Evan A. Boyle,
  • Oana Ursu,
  • Carlos L. Araya,
  • C. Kimberly Tsui,
  • Michael S. Haney,
  • Gaelen T. Hess,
  • Kyuho Han,
  • Edwin E. Jeng,
  • Amy Li,
  • Michael P. Snyder,
  • William J. Greenleaf,
  • Anshul Kundaje,
  • Michael C. Bassik

DOI
https://doi.org/10.1038/ncomms15178
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 8

Abstract

Read online

CRISPR-Cas9 screens are powerful high-throughput tools but can be confounded by nuclease toxicity. Here the authors design a library of variable length gRNAs with thousands of negative controls, including the targeting of ‘safe’ loci to account for on-target site DNA damage toxicity.